ArticleUrologic oncology2022

Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatment.

Annabel Spek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.